Cancer cell metabolism regulates extracellular matrix degradation by invadopodia

European Journal of Cell Biology

Volumn 92, Issue 3, 2013, Pages 113-121

  Van Horssen, Remco ^a   Buccione, Roberto ^b   Willemse, Marieke ^a   Cingir, Sahika ^a   Wieringa, Bé ^a   Attanasio, Francesca ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Tumor Cell Invasion Laboratory   (Italy)

Author keywords

Cancer metabolism; Cell invasion; Invadopodia; Matrix degradation

Indexed keywords

PYRUVIC ACID; TRICARBOXYLIC ACID;

ARTICLE; CANCER CELL; CARBON SOURCE; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CULTURE MEDIUM; DEGRADATION; EXTRACELLULAR MATRIX; GLYCOLYSIS; HUMAN; HUMAN CELL; INVADOPODIA; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; HUMANS; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; PSEUDOPODIA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84875379535     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.11.003     Document Type: Article

References (58)

1. Attanasio F., Caldieri G., Giacchetti G., van Horssen R., Wieringa B., Buccione R. Novel invadopodia components revealed by differential proteomic analysis. Eur. J. Cell Biol. 2011, 90:115-127.
2. Baldassarre M., Pompeo A., Beznoussenko G., Castaldi C., Cortellino S., McNiven M.A., Luini A., Buccione R. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol. Biol. Cell 2003, 14:1074-1084.
3. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
4. Bhujwalla Z.M. Molecular and functional imaging of cancer. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009, 2009:47-49.
5. Bowden E.T., Coopman P.J., Mueller S.C. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 2001, 63:613-627.
6. Brahimi-Horn M.C., Bellot G., Pouyssegur J. Hypoxia and energetic tumour metabolism. Curr. Opin. Genet. Dev. 2011, 21:67-72.
7. Busco G., Cardone R.A., Greco M.R., Bellizzi A., Colella M., Antelmi E., Mancini M.T., Dell'Aquila M.E., Casavola V., Paradiso A., Reshkin S.J. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 2010, 24:3903-3915.
8. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
9. Caldieri G., Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol. 2010, 20:64-70.
10. Caldieri G., Giacchetti G., Beznoussenko G., Attanasio F., Ayala I., Buccione R. Invadopodia biogenesis is regulated by caveolin-mediated modulation of membrane cholesterol levels. J. Cell. Mol. Med. 2009, 13:1728-1740.
11. Caneba C.A., Bellance N., Yang L., Pabst L., Nagrath D. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E1036-E1052.
12. + exchanger in metastasis. Nat. Rev. Cancer 2005, 5:786-795.
13. Chiche J., Brahimi-Horn M.C., Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J. Cell. Mol. Med. 2010, 14:771-794.
14. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., Fleming M.D., Schreiber S.L., Cantley L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
15. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 2008, 8:51-56.
16. Dang C.V., Le A., Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009, 15:6479-6483.
17. David C.J., Chen M., Assanah M., Canoll P., Manley J.L. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-368.
18. de Groof A.J., Te Lindert M.M., van Dommelen M.M., Wu M., Willemse M., Smift A.L., Winer M., Oerlemans F., Pluk H., Fransen J.A., Wieringa B. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol. Cancer 2009, 8:54.
19. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
20. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., Zhuang H., Cinalli R.M., Alavi A., Rudin C.M., Thompson C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
21. Finger E.C., Giaccia A.J. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 2010, 29:285-293.
22. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
23. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 2010, 9:447-464.
24. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2002, 2:683-693.
25. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
26. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
27. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
28. Hung Y.P., Albeck J.G., Tantama M., Yellen G. Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab. 2011, 14:545-554.
29. Imamura H., Nhat K.P., Togawa H., Saito K., Iino R., Kato-Yamada Y., Nagai T., Noji H. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15651-15656.
30. Jiang P., Du W., Wang X., Mancuso A., Gao X., Wu M., Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13:310-316.
31. Kim J.W., Gao P., Liu Y.C., Semenza G.L., Dang C.V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 2007, 27:7381-7393.
32. Kuiper J.W., Pluk H., Oerlemans F., van Leeuwen F.N., de Lange F., Fransen J., Wieringa B. Creatine kinase-mediated ATP supply fuels actin-based events in phagocytosis. PLoS Biol. 2008, 6:e51.
33. Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O'Donnell K.A., Kim J.W., Yustein J.T., Lee L.A., Dang C.V. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 2005, 25:6225-6234.
34. Lucien F., Brochu-Gaudreau K., Arsenault D., Harper K., Dubois C.M. Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS One 2011, e28851.
35. Magalhaes M.A., Larson D.R., Mader C.C., Bravo-Cordero J.J., Gil-Henn H., Oser M., Chen X., Koleske A.J., Condeelis J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J. Cell Biol. 2011, 195:903-920.
36. Martinez-Zaguilan R., Seftor E.A., Seftor R.E., Chu Y.W., Gillies R.J., Hendrix M.J. Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 1996, 14:176-186.
37. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
38. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., Yang Y., Linehan W.M., Chandel N.S., DeBerardinis R.J. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
39. Nakahara H., Otani T., Sasaki T., Miura Y., Takai Y., Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003, 8:1019-1027.
40. Pichot C.S., Arvanitis C., Hartig S.M., Jensen S.A., Bechill J., Marzouk S., Yu J., Frost J.A., Corey S.J. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Res. 2010, 70:8347-8356.
41. Robey R.B., Hay N. Is Akt the " Warburg kinase" ? - Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 2009, 19:25-31.
42. Salway J.G. Metabolism at a Glance 2004, Blackwell Publ., Oxford. 3rd ed.
43. Scott K.E., Wheeler F.B., Davis A.L., Thomas M.J., Ntambi J.M., Seals D.F., Kridel S.J. Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis. PLoS One 2012, 7:e29761.
44. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
45. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell 2001, 8:317-325.
46. Stock C., Ludwig F.T., Schwab A. Is the multifunctional Na(+)/H(+) exchanger isoform 1 a potential therapeutic target in cancer?. Curr. Med. Chem. 2012, 19:647-660.
47. Van Horssen R., Janssen E., Peters W., van de Pasch L., Te Lindert M.M., van Dommelen M.M., Linssen P.C., ten Hagen T.L., Fransen J.A., Wieringa B. Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J. Biol. Chem. 2009, 284:1620-1627.
48. Van Horssen, R., Willemse, M., Haeger, A., Attanasio, F., Guneri, T., Schwab, A., Stock, C.M., Buccione, R., Fransen, J.A.M., Wieringa, B., 2013. Intracellular NAD(H) levels control motility and invasion of glioma cells. Cell. Mol. Life Sci. in press.
49. Vander Heiden M.G. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 2011, 10:671-684.
50. Vasseur S., Malicet C., Calvo E.L., Dagorn J.C., Iovanna J.L. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development. Mol. Cancer 2005, 4:4.
51. Vizan P., Alcarraz-Vizan G., Diaz-Moralli S., Solovjeva O.N., Frederiks W.M., Cascante M. Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29. Int. J. Cancer 2009, 124:2789-2796.
52. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
53. Wang J.B., Erickson J.W., Fuji R., Ramachandran S., Gao P., Dinavahi R., Wilson K.F., Ambrosio A.L., Dias S.M., Dang C.V., Cerione R.A. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010, 18:207-219.
54. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
55. Warburg O., Posener K., Negelein E. Uber den stoffwechsel der carcinomzelle. Biochem. Ztschr. 1924, 152:309-344.
56. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., McMahon S.B., Thompson C.B. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18782-18787.
57. Yamaguchi H., Oikawa T. Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis. Oncotarget 2010, 1:320-328.
58. Zaytseva Y.Y., Rychahou P.G., Gulhati P., Elliott V.A., Mustain W.C., O'Connor K., Morris A.J., Sunkara M., Weiss H.L., Lee E.Y., Evers B.M. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res. 2012, 72:1504-1517.